The global Traveler’s Diarrhea Therapeutics market is segregated on the basis of Application as Adult Traveler’s Diarrhea and Children Traveler’s Diarrhea. Based on Type the global Traveler’s Diarrhea Therapeutics market is segmented in Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, and Other.
Browse Full Report: https://www.marketresearchengine.com/travelers-diarrhea-therapeutics-market
The global Traveler’s Diarrhea Therapeutics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Traveler’s Diarrhea Therapeutics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Traveler’s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey.
The Traveler’s Diarrhea Therapeutics market is expected to exceed more than US$ 8 Billion by 2024 at a CAGR of 7.1% in the given forecast period.
Incensing number of frequent flyers and flourishing tourism business in developing region is anticipated to drive the market for traveler’s diarrhea treatment market over the study period. The increasing awareness among the end user for advanced traveler’s diarrhea treatment is anticipated to propel the market growth for traveler’s diarrhea treatment market. The ease and convenience in obtaining drugs and availability of over the counter medications is anticipated to offer lucrative growth opportunities for the traveler’s diarrhea treatment market. The advantage offered by vaccines used in cholera in treatment of traveler’s diarrhea is anticipated to impel the market growth for traveler’s diarrhea treatment. However, side effects associated with the antimicrobial drugs and associated depletion of the digestive flora is anticipated to restrain the market for traveler’s diarrhea treatment.
The report covers:Global Traveler’s Diarrhea Therapeutics market sizes from 2015 to 2024, along with CAGR for 2018-2024 Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024 Global Traveler’s Diarrhea Therapeutics market trends, covering comprehensive range of consumer trends & manufacturer trends Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Traveler’s Diarrhea Therapeutics market Major market opportunities and challenges in forecast timeframe to be focused Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management Comprehensive company profiles of the key industry players
Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron and others are among the major players in the global Traveler’s Diarrhea Therapeutics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Traveler’s Diarrhea Therapeutics Market has been segmented as below:
Traveler’s Diarrhea Therapeutics Market, By ApplicationAdult Traveler’s Diarrhea Children Traveler’s Diarrhea
Traveler’s Diarrhea Therapeutics Market, By TypeImmunization Non-antibiotic Agents Antibiotics Anti-Motility Agents Other
Traveler’s Diarrhea Therapeutics Market, By RegionNorth America Europe Asia-Pacific Rest of the World
Traveler’s Diarrhea Therapeutics Market, By CompanySalix Pharmaceuticals P&G Johnson & Johnson Otsuka Pharma Valneva Shanghai United Cell PaxVax Livzon Immuron
The global Traveler’s Diarrhea Therapeutics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Traveler’s Diarrhea Therapeutics market share. Major industry players with significant revenue share include Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron, and others.
Reasons to Buy this Report:Gain detailed insights on the Traveler’s Diarrhea Therapeutics industry trends Find complete analysis on the market status Identify the Traveler’s Diarrhea Therapeutics market opportunities and growth segments Analyse competitive dynamics by evaluating business segments & product portfolios Facilitate strategy planning and industry dynamics to enhance decision making
Request Sample Report from here: https://www.marketresearchengine.com/travelers-diarrhea-therapeutics-market
Table of Contents:Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis Executive Summary Market Overview
4.2 Porter’s Five Force Analysis Traveler’s Diarrhea Therapeutics Market, By Application Traveler’s Diarrhea Therapeutics Market, By Type Traveler’s Diarrhea Therapeutics Market, By Geography Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others Company Profiles
9.1 Salix Pharmaceuticals
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Johnson & Johnson
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Otsuka Pharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Shanghai United Cell
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
Other Related Market News :
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States